Star Mountain Resources is a precious metals mining company focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District in Beaver County, Utah. The company’s primary project in the region, the Chopar Mine project, consists of 116 lode-mining claims and four metalliferous mineral lease sections located within a 2,320 acre area approximately five miles west of Milford, Utah. To date, SMRS’s exploration efforts have included geological analysis and a limited reverse circulation and core drilling program.

In January, SMRS took a major step toward making the Chopar project financially viable by retaining geological research and consulting company Mine Mappers, LLC. Through this partnership, the company will be able to more effectively evaluate prior exploration history and prepare a scope of work for a comprehensive exploration program to thoroughly evaluate the mineral potential of its holdings. In particular, the district’s high potential for large concentrations of skarn, which is a type of rock commonly associated with mineable accumulations of metallic ores, is an encouraging indication for SMRS moving forward.

“The presence of skarn mineralization in outcrop, in historic mines and in drill core and chips is encouraging,” Dr. Mark Osterberg, president and chief operating officer of SMRS, stated in a news release. “The extent of zones affected by contact metasomatism is potentially large enough to host ore bodies of size and grade to interest junior and major mining concerns.”

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. Despite prior mining efforts, the company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region’s mild climate and accessibility to nearby rail lines and roads, SMRS will look to translate this potential into sustainable returns in the years to come.

SMRS will utilize a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, SMRS will also continue to seek quality projects that can be evaluated on their own technical and financial merit.

For prospective investors, the company’s continued exploration of its Chopar project could provide a strong platform to realize significant returns. Look for SMRS to continue to explore the geological environments of its leasehold in the coming months in an effort to determine the presence of potentially viable copper or gold deposits.

For more information, visit www.starmountainresources.com

DATATRAK International, Inc. (OTCQX: DTRK) is a worldwide technology services company delivering unified eClinical® solutions and related services designed to safely accelerate every drug, biologic and device from concept to cure. The company’s proprietary DATATRAK ONE® Unified Experience™ platform provides users with an all-in one clinical enterprise solution complete with all of the necessary components to effectively design, deliver and manage clinical trials. DATATRAK’s groundbreaking software solution currently supports preclinical through phase IV drug and device studies in multiple languages around the world.

Earlier this month, DATATRAK built on its industry-leading software suite through the introduction of UX CTMS 360™. Using this revolutionary startup solution, clinical trials can be initiated at the click of a button without the need for programming expertise. By effectively eliminating the risks and time required to integrate data across multiple systems, the company’s clinical trial management system provides clients with an immediate return on investment.

“The industry has struggled long enough with data silos and expensive third party consulting fees,” Laurence P. Birch, chairman and chief executive officer of DATATRAK, stated in a news release. “With the introduction of UX CTMS 360, we strip away that complexity and expense… [providing] an immediate view of all clinical and operational data across studies.”

In recent months, DATATRAK has made significant progress toward expanding its market share in the life sciences market. In the first quarter of 2015, the company recorded a 35 percent year-over-year increase in new contract sales as a result of continued investment in sales and marketing efforts. This increase in contract sales resulted in a backlog of $27.8 million, an increase of 7 percent over the end of 2014. In April, the company laid the groundwork for continued improvement in the future by opening its Chicago office, expanding its physical presence in one of the country’s leading life sciences markets.

“The success we’re seeing in new contract sales is a positive for the business overall,” continued Birch. “New clients often become our most dedicated partners, setting the stage for future revenue growth.”

For more information, visit www.datatrak.com

The continually evolving healthcare market presents significant challenges for sector operators; not only when it comes to complying with the latest regulatory demands, but the complex logistical realities of patient care as well. MIT Holding (OTC: MITD) has assembled a unique mix of offerings that allows it to act, via a growing portfolio of contractual and affiliate agreements, as well as key licenses, in the role of a single-source provider to a variety of outpatient service and other markets. One of the most important relationships established by the company is with the originator of automated, on-demand online referral packets, Curaspan Health Group. Curaspan, a recognized Health Information Exchange and Patient Transition software company that helps connect providers, payers and suppliers through secure patient-transition network technologies and assists patients through their transition between different phases of care, is an important ally for MIT Holding’s ability to deliver winning solutions across the aforementioned markets, which are rapidly expanding as more and more people realize the benefits of outpatient care.

Markets like in-home infusion therapy, or the administration of medication through (typically) injection or catheter, is one of the top service areas enabled by MIT Holding’s contract with Curaspan. In-home infusion therapy has proven to be as safe and effective as inpatient care across for many diseases, is more convenient and comfortable for the patient, and generally results in better care and patient outcomes.

The contract provides MIT Holding access to a real-time market consisting of the patients from over 5,400 Curaspan affiliated medical facilities. By sending out a registered nurse to consult with the patient, conduct the administration of infusion care, help establish the patient’s medication and equipment needs in greater detail, as well as make determinations about any follow up appointments, additional therapy, or billing and insurance, MIT Holding is able to establish tightly-knit relationships and a stable commercial footprint.

Furthermore, MIT Holding – which specializes in providing an entire menu of such in-home recovery services and even operates ambulatory centers in Georgia through its subsidiaries – liaises directly with customers and is able to establish meaningful contact before the patient even leaves the healthcare facility. This personal contact allows the MIT Holding representative to map out a comprehensive home recovery template tailored to the individual.

With direct contact and MIT Holding’s tailored approach, outpatient care becomes an easy option for the end user, even before the cost savings over staying in the hospital have entered the equation.

The in-home infusion segment of the outpatient market alone is headed steadily upward from the $15.9 billion seen last year and is expected to reach a global market of over $26.7 billion within just the next five years (Persistence Market Research), growing at a CAGR of around 9.0 percent on the strength of increasingly aged populations around the globe, and increasing incident rates of chronic diseases which require infusion therapy.

This is particularly true in North America and Europe, infusion therapy’s two largest markets, where antibiotics and anti-infective indications represent the mainstay for major sector players like Baxter (NYSE: BAX) and CareFusion (NYSE: CFN), and are set to outpace the underlying infusion therapy market by around 0.8 percent CAGR over the same interval.

By 2050, 19 percent of the U.S. population will be over the age of 65; the incidence rate of chronic conditions is expected to follow suit, with estimates that over 170 million Americans will suffer some form of chronic disease by as early as 2030 (Harris Williams & Co.).

At the same time, the Patient Protection and Affordable Care Act (ACA) will continue to bring huge numbers of previously uninsured patients into the market. With nearly 11.7 million of the previously forecast 32 million uninsured set to be covered under the ACA already added to the rolls in state and federal marketplaces as of March 2015, according to Health and Human Services Secretary Sylvia Mathews Burwell, we are already starting to see the leading edge of this massive trend. The implications for outpatient care could be enormous.

For an in-home comprehensive health recovery services company like MIT Holding, this underlying phenomenology will continue to be a growth driver for many years to come, undergirding the company’s business model with a firm foundation that will only increasingly seek out the convenience and savings benefits its service offerings can provide. Taking care of the patient’s needs from hospital discharge through to recovery, and yet being able to provide as much as a 90 percent savings over equivalent care if it took place in a hospital setting, is a key factor that will continue to fuel MIT Holding’s revenue fire, helping the company extend the success of a profitable 2014. First quarter 2015 revenues were double that of the year prior.

The company also rents and sells robust medical equipment for the home, a market on track to hit $12.6 billion by 2018 in the U.S. alone, according to a study published last year by market analysts Freedonia, growing at a CAGR of 8.2 percent from the roughly $8.5 billion seen last year. The increase in chronic diseases like cancer, kidney failure and respiratory disorders will be a major contributing factor to rising demand for hardware like oxygen concentrators needed for COPD (chronic obstructive pulmonary disease) and the like.

Another key advantage MIT Holding has is access to specialty drugs and custom compound pharmaceuticals, allowing the company to cost effectively address the medicinal needs of its patient customers and offer compelling availability/affordability advantages. With the specialty pharmaceuticals market at over $78 billion last year (Drug Channels Institute), MIT Holding is in a prime position to compete with the 250 plus URAC-accredited (Utilization Review Accreditation Commission) specialty pharmacies out there (including about 100 “In Process” companies expected to achieve accreditation this year), possessing an established customer pool that is built on comprehensive services and face-to-face contact. The company also distributes wholesale pharmaceuticals in the U.S. and overseas via its subsidiaries.

With MIT Holding and its affiliates now able to direct bill and receive payments from over 138 of the country’s top regional and national carriers on behalf of patients, carriers like Medicare/Medicaid, as well as major players like Aetna (NYSE: AET) and Cigna (NYSE: CI), the company is now more confident than ever about its business model. The company leverages a model built on the medical and financial benefits of a smooth patient transition that takes them all the way through from their discharge at the hospital to recovery within the comfort and familiarity of their own home.

Learn more by visiting the company’s newly overhauled website at www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

Net Element, which operates a payments-as-a-service platform for small to medium enterprises (“SME”) in the U.S., Russian Federation and other international markets, today officially announced that payment solutions provider PayOnline has released a new mobile payments solution for iOS (iPhone or iPad) mobile apps.

Net Element currently manages, operates and is in the process of integrating the PayOnline group of companies pending closing of Net Element’s acquisition of the company.

The new software developer kit (SDK) enables integration of PayOnline transaction processing into iPad and iPhone apps. Ural Airlines, Russia’s sixth largest airline, is one of the first PayOnline clients to accept payments using an iOS app.

PayOnline estimates 19 percent of its online payments processed during the first quarter were via mobile — an increase of 157 percent year-over-year, with 59 percent of those being iOS (iPhone, iPad).

“Our Pay-Mobile solution combines cutting edge mobile payments innovation with stability and security, baseline components of all PayOnline products,” Marat Abasaliev, general director of PayOnline, stated in the news release.

For more information visit www.netelement.com

Auxilio, Inc. (OTCQB: AUXO) is a leading provider of printer volume, device management and data security process improvement solutions for many of the nation’s top hospitals and health systems. Under its unique business model, the company takes full responsibility for healthcare customers’ on-site print environment, providing hospitals with a collection of potential benefits – including reduced operational costs, increased employee productivity and improved patient care standards. Auxilio’s extensive national portfolio currently includes a network of over 220 hospital campuses managing over 1.5 billion documents each year.

In recent years, Auxilio has utilized an acquisition-based growth strategy to rapidly increase its market share in the healthcare industry. In 2014, the company acquired Delphiis, an information security consulting and SaaS technology provider. Shortly after the acquisition, Auxilio expanded its presence in the industry through the launch of its security solutions group, which helps hospitals and health systems develop strategies to mitigate risk. In March, the company built on this growth through the acquisition of Redspin, a leading provider of security risk assessment and penetration testing services for the healthcare industry.

“This [Redspin] acquisition fits squarely with our strategy of identifying complementary technology and services, led by dynamic leaders who understand the market, have the ability to scale and who can help us take this business to the next level,” Joseph J. Flynn, president and chief executive officer of Auxilio, stated in a news release.

In the first quarter of 2015, Auxilio recorded $13.8 million in total revenue, realizing a 35 percent year-over-year increase. In addition to improved results from its security offerings, the company secured a five-year contract for managed print services (MPS) with one of the largest health systems in the United States, which could provide the company with revenue of more than $50 million over the next five years.

“We are pleased to see the initial stages of a new growth trend from both MPS and our security solutions group and expect continued momentum through 2015,” continued Flynn. “Our goal is to invest in areas of our business where we can garnish the best returns, including business with shorter sales cycles and recurring, higher margin revenues.”

For prospective shareholders, Auxilio’s rapid growth within the medical industry makes it an intriguing investment opportunity moving forward. As the company continues to expand the market share of its security offerings and build on the established presence of its MPS, Auxilio is in a strategic position to realize sustainable returns in the years to come.

For more information, visit www.auxilioinc.com

Accuride Corp. is a leading manufacturer and supplier of components to the North American commercial vehicle industry. The company’s products – including steel and aluminum commercial vehicle wheels, wheel end components and assemblies, and truck body and chassis parts – are marketed under some of the automotive industry’s most recognizable brand names, such as Accuride®, Gunite® and Brillion™. Through a diversified customer base that includes substantially all of the leading commercial vehicle original equipment manufacturers (OEM), Accuride has established a formidable position atop the automotive component market.

In May, Accuride built upon its impressive customer base through the execution of a multi-year agreement with one of the leading all-makes parts brands in the commercial transportation industry, Daimler Trucks North America. According to the terms of this agreement, Accuride will supply its American-made Gunite brake drums, which offer first-fit quality and reduced stopping distance (RSD) compliance, to Daimler’s aftermarket parts group.

“We are pleased to have been chosen as Daimler’s primary aftermarket wheel end supplier and appreciate this expression of confidence… in the quality, dependability and performance of our made-in-the-USA Gunite brake drums,” Rick Dauch, president and chief executive officer of Accuride, stated in a news release.

Accuride plans to supply the entirety of the Daimler drums from its Gunite wheel end component production facility in Rockford, Illinois, which is one of its nine technologically-advanced facilities located across North America. The company’s substantial investments in advanced machining technology and rigorous quality processes should allow Accuride to continue building on its reputation within the industry moving forward.

In recent months, Accuride has continued to post improved financial results. During the first quarter of 2015, the company recorded $183.7 million in net sales, realizing a year-over-year increase of over 10 percent. This growth can be attributed to the strong performance of the North American truck and trailer production industry. In addition to strong production increases across both medium and heavy duty truck classes, forecast increases in freight tonnage throughout the next several years will continue to drive increased demand for Accuride’s manufacturing capabilities.

For prospective investors, Accuride provides significant promise through its established and growing presence in the thriving commercial vehicle industry. Look for the company to continue leveraging deals with leading commercial vehicle OEMs in order to continue promoting sustainable returns in the months to come.

For more information, visit www.accuridecorp.com

Imagenetix, Inc. (OTC: IAGX) is an innovator of natural bioceutical products designed to enhance human health on a global basis. By concentrating on human and animal conditions related to inflammation and obesity, the company has achieved significant advancements in the successful research, development and commercialization of safe compositions to reduce body fat and enhance overall body composition. In particular, Imagenetix develops and formulates proprietary over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution.

In addition to these products, Imagenetix is currently undertaking research and development initiatives based on a cascade of inflammatory events shown to be correlative to a number of diseases. The company’s first therapeutic drug, 1-TDC, was developed for the treatment and prevention of periodontal disease, and, according to studies by Boston University, the drug is effective in halting the progression of gum and bone damage.

Data from the Centers for Disease Control and Prevention shows the massive market potential for 1-TDC moving forward. According to the report, approximately 50 percent of all American adults aged 30 or over suffers from periodontal disease. In adults 65 or older, prevalence rates rise dramatically to approximately 70 percent of individuals.

“We are excited with… the potential of our compound to become a major breakthrough for the prevention of periodontal disease,” William P. Spencer, president of Imagenetix, stated in a news release. The prevalence of the disease among Americans “creates a potential multi-billion [dollar] market for a product developed from our compound.”

In recent years, the company’s primary product has been Celadrin. This medically and clinically proven pain management compound has been shown to dramatically reduce inflammation and pain, providing Imagenetix with access to another market with near limitless potential for growth in the future.

Through a balance of research and development initiatives and continued marketing of its existing product offerings, Imagenetix could be in a strong position to realize increased market share in the years to come. For prospective shareholders, the company’s established presence within the over-the-counter pharmaceutical industry makes it an interesting investment opportunity moving forward.

For more information, visit www.imagenetix.com

Houston-based ENGlobal Corp. (NASDAQ: ENG) operates as an energy-related automation and engineering company operating through strategic business units to provide its services to the global energy and government sectors.

ENGlobal’s Automation segment focuses on the design, fabrication and implementation of distributed control, instrumentation and process analytical systems, as well as products and services supporting the environmental technology fields.

The Engineering (EPCM) segment provides consulting services for the development, management and execution of projects requiring professional engineering, construction management, and related support services. Within this segment, ENGlobal’s Government Services group provides engineering, design, installation and operation and maintenance of various government, public sector and international facilities, and specializes in the turnkey installation and maintenance of automation and instrumentation systems for the U.S. defense industry worldwide.

Additionally, ENGlobal’s Subsea Controls and Integration (SCI) group provides advanced process automation design, engineering service and equipment for the effective integration of communication protocols between topsides production facilities and subsea devices.

ENGlobal is one of a couple publicly traded engineering firm using Houston as an anchor for a worldwide focus. Among them is KBR, Inc. (NYSE: KBR), which recently divested its Building Group subsidiary as part of its restructuring plans announced last December.

KBR serves the global hydrocarbons and government services industries and, along with ENGlobal, which consistently makes the list, was ranked by Engineering News Record magazine as a Top 500 engineering design firm in 2015.

Another market participant on the top ranking list is Jacobs Engineering Group, Inc. (NYSE: JEC). Based in Pasadena, California, Jacobs Engineering also has a global reach and was recently appointed by Managing Contractor Lend Lease Building Pty Ltd. for a major extension to an existing contract for the New Air Combat Capability (NACC) facilities project in Australia.

Though a similar market participant in terms of offerings, ENGlobal’s smaller market cap (ENG $40.0M vs. KBR $2.8B, and JEC $5.3B) and lower trading price (ENG under $2 vs. KBR, just under $20, and JEC around $42) makes it a budget friendly option for investors looking to add a cheaper, but long-standing and reputable engineering firm to their portfolio.

In its nearly 30 years of operations, ENGlobal has created a global workforce of more than 400 industry leaders in a variety of fields, ranging from drafters and designers to technical specialists, all of which are led by a highly experienced core management team with years of industry experience.

William Coskey, founder of ENGlobal, leads the company as its president and CEO. Coskey is supported by Mike Harrison, senior vice president of business development, who worked for Jacobs Engineering from 1996-2005, among other previous roles; and vice president of human resources Scott Curd, who spent 14 years with KBR as senior human resources manager.

Backed by an established business model, decades of operations, and a leadership team leveraging recent as well as previous experience working for larger industry firms, ENGlobal is well-positioned to enjoy the opportunities of the broader global automation and engineering markets.

For more information, visit www.englobal.com

If the caliber of national brands listed on Mobivity’s roster of clients is any inclination, the mobile marketing technology company has hard-earned its reputation for helping businesses and brands foster customer loyalty and reap the financial benefits of doing so.

Using its suite of patented mobile marketing technologies, Mobivity’s communication strategies are designed to enhance customer engagement and loyalty to drive ultimately incremental sales and profitability.

The company’s SmartReceipt technology, for example, transforms traditional retail transaction receipts into engaging “smart” receipts. Mobivity recently announced a deal with U-Swirl, Inc., an operator and franchisor of self-sever frozen yogurt cafes, in which U-Swirl will use the SmartReceipt technology to craft highly targeted, relevant loyalty messages to its customers via SMS text messaging and receipts given at the time of sale.

The technology enables U-Swirl customers to join various loyalty and rewards programs, as well as receive targeted offers and promotions, by subscribing to text messaging programs or through relevant content on their receipts. Following product testing, U-Swirl gave the SmartReceipt technology impressively high marks.

“Our early tests have been extremely well received by our customers,” Carell Grass, vice president of Operations of U-Swirl, stated in the news release. “Response rates to text messaging promotions have been as high as 71%, which is unparalleled. The ability to anchor our digital loyalty program to our point-of-sale systems and receipt content was a key differentiator that attracted us to the Mobivity solutions, and the results speak for themselves.”

U-Swirl joins a client base of national brands including CNN, Disney (NYSE:DIS), the NFL, Sony Corp. (NYSE:SONY) subsidiary Sony Pictures, AT&T (NYSE:T), Chick-fil-A, NBC Universal, Subway, Baskin Robbins, Jamba Juice (NASDAQ:JMBA), Sonic (NYSE:SONC), numerous professional sports teams, as well as thousands of small, local businesses across the U.S.

In the first quarter of 2015, in which Mobivity reported increase in revenues and gross margins, CEO Dennis Becker said SmartReceipt™ has processed more than 680 million transactions and is on track to reach 1 billion transactions later this year. He also described how the company’s current and expanding list of prospective customers is setting it up for anticipated growth.

“Momentum is continuing both in new deployments of SmartReceipt as well as our growing pipeline of potential customers. We are in active discussions with dozens of national QSR brands regarding SmartReceipt™ as well as other components of our unique bundled marketing solution,” Becker stated. “Our technology is powering marketing campaigns for thousands of QSR locations across the U.S. and we anticipate new deployments by additional QSR brands in the current quarter and throughout 2015.”

For more information visit www.mobivity.com

Following up on the major milestone of breaking the 40 million radio transmissions mark with the single-source, web-based event planning, incident management, emergency response and recovery-focused unified communications platform ReadyOp™, Cleartronic, Inc. (OTC: CLRI) has subsequently announced a three-year agreement to participate in HGACBuy, the cooperative purchasing program established by a political subdivision of the State of Texas, the H-GAC (Houston-Galveston Area Council). With HGACBuy’s participating membership of over 6k different government agencies and NPOs, Cleartronic has thusly tapped a major retail vector for the ReadyOp platform, which is being marketed and promoted under CLRI’s wholly-owned ReadyOp Communications subsidiary.

In addition to this major new market addition, the company has just announced a landmark project with one of the biggest retail corporations in Arkansas. Slated to take place over the next three years and focused on bringing the ReadyOp platform to bear on the sprawling planning, monitoring and reporting requirements of the client’s diverse retail location network, this latest announcement shows the power of the revolutionary ReadyOp platform as a unified communications solution that is capable of transmitting data, as well as speech, via a simplified and easy to use web-based portal. This web-based portal approach largely eliminates the need for cumbersome software installs and updates, as is the case with many competitors in this area and yet the platform provides the same kind of highly-secure, mission-critical situational awareness that government agencies rely on for emergency response.

This same robust capability extended to corporations and other commercial entities, which have extensive field personnel teams and diverse logistical footprints, could quickly evolve into significant new business segment for the company and lead to the ReadyOp platform’s standardization among many other retailer operations. The attractiveness of such an easy to use, easy to implement, and yet highly secure unified communications platform is easy to understand for anyone who has ever popped the hood on the complex logistics of today’s big-box retail operations. The immediate appeal to managers of such a system – which would allow scattered personnel across the country to coordinate efforts in real-time, settling issues like inventory loads and communicating crucial operational updates instantly, irrespective of who is using what device in an increasingly BYOD workplace environment – cannot be overstated.

Implementing ReadyOp with this major Arkansas retailer will further validate the platform beyond its core first responder and government agency markets, opening up ReadyOp for use by additional entities across many different industries, all of whom share similar needs to unify communications, irrespective of device, via a single-source virtual framework that allows real-time speech, text, and data transmissions. This initial entry into the retail market is a huge opportunity for CLRI’s ReadyOp Communications subsidiary and will form a success template that can be farmed out to other retailers across the country, hopefully up-selling itself on the efficiency and connectivity advantages conferred on the retailer subsequent to the platform’s adoption.

Cleartronic has hitherto been best known for their patented radio IP gateways and unified communications solutions developed under their VoiceInterop subsidiary, which has an established track record for creating device agnostic solutions that embrace open-standards software, as well as extremely flexible system designs that allow for unprecedented deployment fluidity. That is why budget-constrained local government agencies like law enforcement and fire departments have flocked to the company’s solutions, confident that a mix of AudioMate 360 radio IP gateways used to tie-in radio handsets, and the company’s proprietary software and third party apps, will allow them to span even difficult terrain and create a real-time environment for the exchange of crucial information across a network that also dovetails in everything from traditional phones to PCs, tablets, and smartphones.

The arrangement with Collabria to market their powerful ReadyOp platform markedly enhances the company’s overall portfolio of unified communications offerings and has already led to numerous key contracts or other arrangements. Cleartronic is rapidly establishing itself as one of the front runners in truly 21st century unified communications, and this latest move to boldly expand beyond their core markets into retail and other industries arguably marks the start of what could be a significant growth phase in the company’s history.

Learn more about the company by visiting www.cleartronicinc.com

Or take a closer look at the ReadyOp platform by visiting www.readyop.com

Let us hear your thoughts: Cleartronic, Inc. Message Board